TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Guillain-Barre Syndrome Market, by Type
6.1 Introduction
6.2 Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)
Market Estimates & Forecast, 2020โ2027
6.3 Miller Fisher syndrome (MFS)
Market Estimates & Forecast, 2020โ2027
6.3 Acute Motor Axonal Neuropathy (AMAN)
Market Estimates & Forecast, 2020โ2027
6.4 Others
Chapter 7. Global Guillain-Barre Syndrome Market, by Diagnosis
7.1 Introduction
7.2 Lumbar Puncture
Market Estimates & Forecast, 2020โ2027
7.3 Electromyography
Market Estimates & Forecast, 2020โ2027
7.3.1 Intramuscular EMG
7.3.1 Surface EMG
7.4 Nerve Conduction Studies
Market Estimates & Forecast, 2020โ2027
7.5 Others
Chapter 8. Global Guillain-Barre Syndrome Market, by Treatment
8.1 Introduction
8.2 Plasmapheresis
Market Estimates & Forecast, 2020โ2027
8.3 Medication
Market Estimates & Forecast, 2020โ2027
8.3.1 Privigen Intravenous
8.3.2 Gammagard Liquid Injection
8.3.3 Flebogamma DIF Intravenous
8.3.4 Bivigam Intravenous
8.4 Physical Therapy
Market Estimates & Forecast, 2020โ2027
8.5 Hydrotherapy
Market Estimates & Forecast, 2020โ2027
8.6 Others
Chapter 9. Global Guillain-Barre Syndrome Market, by End-User
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, 2020โ2027
9.3 Diagnostic Centers
Market Estimates & Forecast, 2020โ2027
9.4 Others
Chapter 10. Global Guillain-Barre Syndrome Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K.
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Grifols
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 Baxter
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 CSL Behring
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Akari Therapeutics Plc
12.4.1 Company Overview
12.4.2 Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 ANNEXON, INC.
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Curavac
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Hansa Medical
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Vitality Biopharma
12.8.1 Overview
12.8.2 Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Covidien Limited
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Natus Medical Inc.
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Electrical Geodesics Inc.
12.11.1 Overview
12.11.2 Type Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Guillain-Barre Syndrome Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Guillain-Barre Syndrome Industry Synopsis, 2020โ2027
Table 2 Global Guillain-Barre Syndrome Market Estimates & Forecast, 2020โ2027, (USD Million)
Table 3 Global Guillain-Barre Syndrome Market, by Region, 2020โ2027, (USD Million)
Table 4 Global Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 5 Global Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 6 Global Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 7 Global Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million
Table 8 North America Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 9 North America Guillain-Barre Syndrome, by Diagnosis, 2020โ2027, (USD Million)
Table 10 North America Guillain-Barre Syndrome, by Treatment, 2020โ2027, (USD Million)
Table 11 North America Guillain-Barre Syndrome, by End-User, 2020โ2027, (USD Million)
Table 12 U.S. Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 13 U.S. Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 14 U.S. Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 15 U.S. Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 16 Canada Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 17 Canada Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 18 Canada Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 19 Canada Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 20 South America Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 21 South America Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 22 South America Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 23 South America Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 24 Europe Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 25 Europe Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 26 Europe Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 27 Europe Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 28 Western Europe Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 29 Western Europe Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 30 Western Europe Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 31 Western Europe Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 32 Eastern Europe Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 33 Eastern Europe Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 34 Eastern Europe Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 35 Eastern Europe Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 36 Asia Pacific Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 37 Asia Pacific Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 38 Asia Pacific Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 39 Asia Pacific Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
Table 40 Middle East & Africa Guillain-Barre Syndrome Market, by Type, 2020โ2027, (USD Million)
Table 41 Middle East & Africa Guillain-Barre Syndrome Market, by Diagnosis, 2020โ2027, (USD Million)
Table 42 Middle East & Africa Guillain-Barre Syndrome Market, by Treatment, 2020โ2027, (USD Million)
Table 43 Middle East & Africa Guillain-Barre Syndrome Market, by End-User, 2020โ2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Guillain-Barre Syndrome Market
Figure 3 Market Dynamics for Global Guillain-Barre Syndrome Market
Figure 4 Global Guillain-Barre Syndrome Market Share, by Type 2020
Figure 5 Global Guillain-Barre Syndrome Market Share, by Diagnosis 2020
Figure 6 Global Guillain-Barre Syndrome Market Share, by Treatment, 2020
Figure 7 Global Guillain-Barre Syndrome Market Share, by End-User, 2020
Figure 8 Global Guillain-Barre Syndrome Market Share, by Region, 2020
Figure 9 North America Guillain-Barre Syndrome Market Share, by Country, 2020
Figure 10 Europe Guillain-Barre Syndrome Market Share, by Country, 2020
Figure 11 Asia Pacific Guillain-Barre Syndrome Market Share, by Country, 2020
Figure 12 The Middle East & Africa Guillain-Barre Syndrome Market Share, by Country, 2020
Figure 13 Global Guillain-Barre Syndrome Market: Company Share Analysis, 2020 (%)
Figure 14 Grifols: Key Financials
Figure 15 Grifols: Segmental Revenue
Figure 16 Grifols: Geographical Revenue
Figure 17 Baxter: Key Financials
Figure 18 Baxter: Segmental Revenue
Figure 19 Baxter: Geographical Revenue
Figure 20 CSL Behring: Key Financials
Figure 21 CSL Behring: Segmental Revenue
Figure 22 CSL Behring: Geographical Revenue
Figure 23 Akari Therapeutics Plc: Key Financials
Figure 24 Akari Therapeutics Plc: Segmental Revenue
Figure 25 Akari Therapeutics Plc: Geographical Revenue
Figure 26 ANNEXON, INC.: Key Financials
Figure 27 ANNEXON, INC.: Segmental Revenue
Figure 28 ANNEXON, INC.: Geographical Revenue
Figure 29 Curavac: Key Financials
Figure 30 Curavac: Segmental Revenue
Figure 31 Curavac: Geographical Revenue
Figure 32 Hansa Medical: Key Financials
Figure 33 Hansa Medical: Segmental Revenue
Figure 34 Hansa Medical: Geographical Revenue
Figure 35 Vitality Biopharma: Key Financials
Figure 36 Vitality Biopharma: Segmental Revenue
Figure 37 Vitality Biopharma: Geographical Revenue
Figure 38 Covidien Limited: Key Financials
Figure 39 Covidien Limited: Segmental Revenue
Figure 40 Covidien Limited: Geographical Revenue
Figure 41 Natus Medical Inc.: Key Financials
Figure 42 Natus Medical Inc.: Segmental Revenue
Figure 43 Natus Medical Inc.: Geographical Revenue
Figure 41 Electrical Geodesics Inc.: Key Financials
Figure 42 Electrical Geodesics Inc.: Segmental Revenue
Figure 43 Electrical Geodesics Inc.: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
